Using observational cohort data for studying drug effects on pregnancy outcome--methodological considerations.
about
Methodological Issues in Assessing the Impact of Prenatal Drug ExposurePregnancy outcome following maternal use of zanamivir or oseltamivir during the 2009 influenza A/H1N1 pandemic: a national prospective surveillance study.Observational cohort study of pregnancy outcome after first-trimester exposure to fluoroquinolones.Exposed or not exposed? Exploring exposure classification in studies using administrative data to investigate outcomes following medication use during pregnancy.Allopurinol Use during Pregnancy - Outcome of 31 Prospectively Ascertained Cases and a Phenotype Possibly Indicative for Teratogenicity.Selective serotonin reuptake inhibitors in human pregnancy: to treat or not to treat?Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study.Angiotensin-II receptor 1 antagonist fetopathy--risk assessment, critical time period and vena cava thrombosis as a possible new feature.An International Study of the Ability and Cost-Effectiveness of Advertising Methods to Facilitate Study Participant Self-Enrolment Into a Pilot Pharmacovigilance Study During Early Pregnancy.Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases.Metamizole use during first trimester-A prospective observational cohort study on pregnancy outcome.Outcome of breastfed infants following post-partum methylergonovine treatment.How to take into account exposure to drugs over time in pharmacoepidemiology studies of pregnant women?Does the average drug exposure in pregnant women affect pregnancy outcome? A comparison of two approaches to estimate the baseline risks of adverse pregnancy outcome.Nationwide register-based surveillance system on drugs and pregnancy in Finland 1996-2006.No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study.The role of teratology information services in screening for teratogenic exposures: challenges and opportunities.Pregnancy outcomes in women on metformin for diabetes or other indications among those seeking teratology information services.Pregnancy outcome after anti-migraine triptan use: A prospective observational cohort study.Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.The outcomes of pregnancy in women exposed to the new macrolides in the first trimester: a prospective, multicentre, observational study.Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services.Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study
P2860
Q26775873-D5D1E056-ACEF-417D-B014-7FD2CA09C2BDQ30359847-75E38D87-9657-43FF-82E2-B085A9D97FDBQ34058190-AE595F5E-6E4C-4D22-A7AA-CEDC6DFB941EQ34073546-EE2F3A32-9F6E-453C-AFA6-F68C5568E6BFQ34805821-D00CC8A4-A6E1-4398-B9A8-91B269940E3DQ35608913-80351DB1-B3C6-42F8-9F84-C055F5486A87Q36125487-CEC8660F-EC5E-4971-A95A-327A36F9279FQ36620242-AB6D5AE6-5BCC-43C7-8808-5A7C54EC71B5Q36907082-A28CCC52-44C1-4A09-8A8B-24249B52EA68Q37696080-510535D5-5839-4F73-B0EB-528CAF492853Q38644087-8929A376-2984-4484-AE0B-38F561FF2142Q39185881-C94648C9-F818-4D72-9BAB-D048AFB0B830Q39886560-CE369857-3F6F-42F7-99C6-877E448D93CFQ41491124-D6F5318D-6056-4D2B-86B5-39B666F9576AQ43525170-C873CFCC-A688-4A45-A5BA-D3E86B419AD3Q45929435-ACB53F70-527E-4468-8AF9-63A00EE5DA4DQ46554795-D11A1043-9189-4BC3-A11A-5BA5C53DC435Q47583728-E96CF8A4-7E04-477D-A269-7D82B08BB017Q50431359-C34D0EC6-594A-4614-95A2-5FC802E7F231Q52885913-948DE7C7-A76B-4013-809B-A2F8465317CFQ52887870-4EB249A2-C801-4C19-9CA4-FD12DF2FF8C6Q52889724-172B9EF4-A0B9-4C16-8709-629410BFCFE8Q56964882-4F803B2B-2AF1-4116-B683-81139F1C36EE
P2860
Using observational cohort data for studying drug effects on pregnancy outcome--methodological considerations.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Using observational cohort dat ...... methodological considerations.
@en
type
label
Using observational cohort dat ...... methodological considerations.
@en
prefLabel
Using observational cohort dat ...... methodological considerations.
@en
P2093
P1476
Using observational cohort dat ...... methodological considerations.
@en
P2093
Asher Ornoy
Christof Schaefer
Corinna Weber-Schoendorfer
Maurizio Clementi
Reinhard Meister
P356
10.1016/J.REPROTOX.2008.05.064
P577
2008-06-07T00:00:00Z